(2106–2123) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster II

Tuesday, October 28, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-scale Observational Study
Abstract Poster Presenter: Kinga Grzybowski, MD – Jefferson Einstein Montgomery Hospital
10:30 AM - 12:30 PM Central Time

Comparative Effects of IL-6 inhibition, Methotrexate, and Glucocorticoid Monotherapy on Bone Mineral Density, 3D-DXA femoral structure and Bone Turnover Markers in GCA and PMR
Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
10:30 AM - 12:30 PM Central Time

Cost-effectiveness Analysis of Biosimilar Denosumab for the Treatment of Women with Post-menopausal Osteoporosis in the United States: A Risk Based Analysis
Abstract Poster Presenter: Edward Li, PharmD, MPH (he/him/his) – Sandoz Inc.
10:30 AM - 12:30 PM Central Time

Denosumab Discontinuation and Switching in Glucocorticoid-Induced Osteoporosis: A Multi-site Randomized Clinical Trial
Abstract Poster Presenter: Giovanni Adami, MD – University of Verona, Italy
10:30 AM - 12:30 PM Central Time

Development of a Fracture Prediction Model for Patients Aging with HIV
Abstract Poster Presenter: Evelyn Hsieh, MD, PhD (she/her/hers) – Yale School of Medicine/VA Connecticut Healthcare Center
10:30 AM - 12:30 PM Central Time

Effect of Proton-Pump-Inhibitors on Bone Mineral Density and Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases
Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
10:30 AM - 12:30 PM Central Time

Experience of a Fragility Fracture Coordination Unit Integrated Across Two Hospitals: An Innovative Multidisciplinary Model for Optimizing the Management of Geriatric and Non-Geriatric Patients Beyond Surgery After an Osteoporotic Bone Fragility Fracture
Abstract Poster Presenter: César Antonio Egües Dubuc, MD,MSc (he/him/his) – Hospital Universitario Donostia
10:30 AM - 12:30 PM Central Time

Fracture rates in 6475 individuals with osteogenesis imperfecta stratified by age, sex and clinical severity
Abstract Poster Presenter: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
10:30 AM - 12:30 PM Central Time

METHOFRACT, a methotrexate osteopathy multicentric binational cohort study.
Abstract Poster Presenter: François ROBIN, MD, PhD (he/him/his) – Rennes University
10:30 AM - 12:30 PM Central Time

Mortality rate in patients with hip fracture: is it recommendable to establish fracture units?
Abstract Poster Presenter: Esther Monleon Acosta, -None- – Hospital Santa Lucia
10:30 AM - 12:30 PM Central Time

Multidisciplinary Fragility Fracture Management Across Two Coordinated Hospitals: Evaluating Risk Factors, Treatment Approaches, and Long-Term Patient Outcomes in Those With and Without Prior Fractures
Abstract Poster Presenter: César Antonio Egües Dubuc, MD,MSc (he/him/his) – Hospital Universitario Donostia
10:30 AM - 12:30 PM Central Time

Prevalence and Characteristics of Morphometric Vertebral Fractures in the Spanish Population: Data from the OsteoSER Study
Abstract Poster Presenter: Carmen Gomez Vaquero, MD – Hospital Universitari de Bellvitge
10:30 AM - 12:30 PM Central Time

Prevention of Bone Mass Loss Associated With Aromatase Inhibitors in Breast Cancer. A Study in Real-World Clinical Practice.
Abstract Poster Presenter: Lucia Paz Liñeira, -None- – Hospital General Universitario Gregorio Marañón
10:30 AM - 12:30 PM Central Time

Risks of Fracture in Current and Previous Anticonvulsant Users, An Observational Study
Abstract Poster Presenter: Grace Hyeyeon Lee, MBBS – Newcastle University
10:30 AM - 12:30 PM Central Time

Romosozumab in Multiple Myeloma Patients at High Risk of Fracture
Abstract Poster Presenter: Giovanni Adami, MD – University of Verona, Italy
10:30 AM - 12:30 PM Central Time

Safety and Efficacy of Romosozumab in the Treatment of Patients with High-Risk Fracture Osteoporosis in Clinical Practice: Experience from a Tertiary University Hospital in Spain
Abstract Poster Presenter: Maryia Nikitsina, DM (she/her/hers) – University Hospital la Princesa, Madrid
10:30 AM - 12:30 PM Central Time

Sclerostin in Aging Bone and Muscle: A Comparative Study of Osteoporosis, Sarcopenia, and Osteosarcopenia
Abstract Poster Presenter: Mohamed Tharwat Hegazy, MD, PhD, FACR (he/him/his) – Faculty of Medicine, Cairo University
10:30 AM - 12:30 PM Central Time

Which drugs are associated with the development of osteonecrosis of the jaw? clinical and epidemiological analysis of a cohort of patients diagnosed with osteonecrosis of the jaw.
Abstract Poster Presenter: Esther Monleon Acosta, -None- – Hospital Santa Lucia